AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06013397 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Description: Ketogenic diet (KD) is a high-fat, low-carbohydrate and moderate protein diet pattern, suitable for refractory epilepsy, glucose carrier protein 1 deficiency, pyruvate dehydrogenase deficiency, tumors and some genetic metabolic diseases. The ketogenic diet has been used to treat epilepsy for nearly 100 years, and its safety has been recognized by the medical community. In 2015, the ketogenic diet was included in the Clinical Diagnosis and Treatment Guidelines - Epilepsy Volume and became a commonly used treatment for refractory epilepsy.
Study NCT05717179 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: At baseline and at weeks 12, 24 and 48, patients will undergo an ultrasound examination of 44 joints by one investigator, who is blinded to the strategic arm and all clinical data. The following joints will be assessed: bilateral wrists (distal radio-ulnar joint, radio-carpal, mid-carpal recesses), 1st - 5th MCP, 1st - 5th PIP, elbows, glenohumeral, acromioclavicular, sternoclavicular, knees, ankles and 1st - 5th MTP. At wrists, MCP and PIP joints, palmar and dorsal sites including synovial recess, extensor and flexor tendons will be investigated whereas at feet the dorsal site (plus the lateral aspects of MTP5) including synovial recess and extensor tendons will be evaluated. Further, we will assess the following: at elbows the dorsal and anterior recess, at shoulders the dorsal recess, at knees the suprapatellar as well as the medial and lateral femoro-tibial recess and at ankles the anterior, lateral and medial recess of the tibiotalar joint.
Study NCT04898426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced bowel preparation instruction
Description: Automated delivery of SMS, pre-recorded phone call, and link to an information website.
Study NCT06006858 — intervention group
Intervention type: BIOLOGICAL
Intervention: Moderna COVID-19 Vaccine
Description: Moderna COVID-19 Vaccine is provided as a white to off-white suspension for intramuscular injection. Each 0.5 mL dose of Moderna COVID-19 Vaccine contains 100 mcg of nucleoside-modified messenger RNA (mRNA) encoding the pre-fusion stabilized Spike glycoprotein (S) of SARS-CoV-2 virus.
Study NCT06553378 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Geriatric Oncology Supportive Clinic
Description: Subjects in the intervention arm will be seen within four weeks of recruitment. Clinical assessment involves a Comprehensive Geriatric Assessment (CGA) and Supportive Care Assessment conducted by a geriatric-oncologist. Both clinical assessments and targeted interventions are supported by a multi-disciplinary team comprising the geriatrician, geriatric trained nurse, physiotherapist, occupational therapist, speech therapist, pharmacist, dietician, and medical social worker. We will conduct an initial GOSC assessment, with a follow up review during oncology treatment. Subsequently, further GOSC clinic sessions duration of follow up will be determined by the subject's underlying disease, symptom burden and clinical course during treatment.
Study NCT06276608 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Iron status
Description: Iron status will be based on preoperative ferritin levels: a ferritin \< 10 mcg/L will be considered as iron deficiency, ferritin levels > 10 mcg/L will be considered normal
Study NCT05818800 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: digital solution
Description: randomised controlled trial where patients with hypertension will be randomised either to one of the two digital solutions
Study NCT05818800 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard Care
Description: randomised controlled trial where patients with hypertension will be randomised r to standard care
Study NCT06449755 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Quick DASH Questionnaire
Description: Quick DASH is an 11-question questionnaire that assesses upper extremity functionality.
Study NCT05129982 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: whole body vibration
Description: whole body vibration is a modality of physical therapy
Study NCT05073588 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Indo Mediterranean diet
Description: Mediterranean diet has been shown to be effective in NAFLD adult patients. In India, it is very difficult to follow Mediterranean diet, so one group will be given Indianized version of mediterranean diet.
Study NCT05073588 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Calorie restricted diet
Description: One group will be given diet restricted in calories, which most of the patients follow to lose weight
Study NCT06055751 — intervention group
Intervention type: DEVICE
Intervention: TAVR Procedure and implantation of Boston Scientific Loop Recorder (LUX-Dx PMA# K193473)
Description: No intervention will be done as part of this prospective registry. Implantation of Boston Scientific Loop Recorder (LUX-Dx) will be performed regardless of this research and outside this research protocol per standard of care
Study NCT05944887 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine 2% Injectable Solution
Description: administration of a bolus of lidocaine 1.5 mg/kg
Study NCT05944887 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline administration as placebo
Description: administration of a bolus of saline solution as a placebo
Study NCT05328076 — intervention group
Intervention type: DRUG
Intervention: Indocyanine green
Description: Indocyanine green is used to perform intraoperative angiography.
Study NCT05328076 — intervention group
Intervention type: DEVICE
Intervention: SPY Portable Handheld Imaging (SPY-PHI)
Description: The device is used to perform intraoperative angiography.
Study NCT05944887 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol injection
Description: Sedation by total intravenous administration (TIVA) of propofol
Study NCT05831059 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Pulsed radio frequency therapy
Description: Pulse Radio Frequency mode is a high voltage and low temperature Radio Frequency mode formed by discontinuous and pulsed current around nerve tissue
Study NCT05831059 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Pulsed radio frequency therapy
Description: Pulse Radio Frequency mode is a high voltage and low temperature Radio Frequency mode formed by discontinuous and pulsed current around nerve tissue
Study NCT05831059 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sham operation
Description: The means to achieve double-blind treatment had no practical effect on the subjects
Study NCT05831059 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: sham operation
Description: The means to achieve double-blind treatment had no practical effect on the subjects
Study NCT05944887 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Propofol injection
Description: Sedation by total intravenous administration (TIVA) of propofol
Study NCT05944887 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: gastroscopy
Description: esogastroduodenoscopy
Study NCT05944887 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: gastroscopy
Description: esogastroduodenoscopy
Study NCT06315348 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: flapless alveolar decortication with augmentation
Description: piezocision-assisted orthodontics, concomitant to soft tissue grafting (volume-stable collagen matrix), with piezocision-assisted orthodontics, concomitant to bone grafting with a xenograft and a native collagen membrane. Piezocisions will be performed using a piezoelectric device.
Study NCT06315348 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: flapless alveolar decortication with augmentation
Description: piezocision-assisted orthodontics, concomitant to soft tissue grafting (volume-stable collagen matrix), with piezocision-assisted orthodontics, concomitant to bone grafting with a xenograft and a native collagen membrane. Piezocisions will be performed using a piezoelectric device.
Study NCT06557044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Description: PENG block with ropivacaine
Study NCT06557044 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Physiological saline
Description: Placebo control
Study NCT05069935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FT538
Description: FT538 is an allogeneic natural killer (NK)-cell immunotherapy
Study NCT05069935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Lympho-conditioning agent
Study NCT05069935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Lympho-conditioning agent
Study NCT05069935 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Monoclonal antibody - Dose Escalation
Description: either avelumab, trastuzumab or cetuximab
Study NCT05069935 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Monoclonal antibody - Dose Expansion
Description: either avelumab, atezolizumab, nivolumab, pembrolizumab, trastuzumab or cetuximab
Study NCT06295094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 10.5 mg/m2 body surface in 150ml saline
Study NCT06295094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: 2.1 mg/m2 body surface in 50ml saline
Study NCT05543694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Hydrochloride
Description: Subjects will receive a dose of bupivacaine as described in the arm section of this trial
Study NCT05543694 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Hydrochloride
Description: Subjects will receive a dose of bupivacaine as described in the arm section of this trial
Study NCT05397795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10000 IU hCG (Choriomon5000 IU; IBSA)
Description: 10000 IU of hCG (Choriomon5000 IU; IBSA) given intramuscularly
Study NCT05397795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring)
Description: GnRH agonist triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring) subcutaneously.
Study NCT04980248 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ALXN1850
Description: ALXN1850 will be administered as an IV infusion and via the SC route.
Study NCT05701111 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Start with the Heart Students
Description: The Start with the Heart curriculum includes psychoeducation, lessons, and activities, on mindfulness, neurobiology, meditation, positive thinking, movement, and nutrition to promote well-being. The curriculum will be taught in the classroom to students for 15-20 min per day for 6-8 weeks.
Study NCT05701111 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Start with the Heart Students
Description: The Start with the Heart curriculum includes psychoeducation, lessons, and activities, on mindfulness, neurobiology, meditation, positive thinking, movement, and nutrition to promote well-being. The curriculum will be taught in the classroom to students for 15-20 min per day for 6-8 weeks.
Study NCT05701111 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Start with the Heart Teachers
Description: Pure Edge Inc will train teachers to deliver the Start with the Heart curriculum. The training emphasizes the neuroscience of stress and educator self-care. The teachers will implement the training in their respective classrooms for 6-8 weeks.
Study NCT05701111 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cue Centered Therapy Counselors
Description: The Early Life Stress and Resilience Program team members will train school counselors on Cue-Centered Therapy through self-paced online modules, virtual and in-person live training, and office hours as needed. Counselors will implement the intervention with eligible students for 15-18 weeks.
Study NCT05701111 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cue Centered Therapy Students
Description: Students who report a threshold of PTSD symptoms will be offered participation in Cue-Centered Therapy with their school counselors. They will have one-on-one therapy that targets trauma experiences through cognitive behavioral tools, narrative therapy, exposure therapy, psychoeducation, and more. Their caregivers will be involved as needed. They will enroll in treatment for 15-18 weeks.
Study NCT05701111 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cue Centered Therapy Students
Description: Students who report a threshold of PTSD symptoms will be offered participation in Cue-Centered Therapy with their school counselors. They will have one-on-one therapy that targets trauma experiences through cognitive behavioral tools, narrative therapy, exposure therapy, psychoeducation, and more. Their caregivers will be involved as needed. They will enroll in treatment for 15-18 weeks.
Study NCT05701111 — intervention group
Intervention type: GENETIC
Group type: OTHER
Intervention: iSWAB-DNA
Description: Eligible students will give DNA buccal swabs at 2-3 time points for later analysis of genetic markers.
Study NCT05745896 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedicine appointment
Description: Three online appointments for pregnancy monitoring at prenatal care.
Study NCT05745896 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Face-to-face appointment
Description: Six to nine face-to-face appointments for pregnancy monitoring at prenatal care.
Study NCT05745896 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Face-to-face appointment
Description: Six to nine face-to-face appointments for pregnancy monitoring at prenatal care.
Study NCT05129813 — intervention group
Intervention type: BEHAVIORAL
Intervention: Recovery Guide Counseling
Description: Recovery Guide Counseling is a 12-session psychoeducational and behavioral counseling intended for delivery by Peer Recovery Specialists, community health workers, or other personnel without advanced training in counseling
Study NCT05186779 — intervention group
Intervention type: DRUG
Intervention: Progestagen
Description: Subjects receiving treatment with any progestogen, including dydrogesterone, or other treatment in the first trimester of pregnancy following; (Cohort A) a diagnosis of early bleeding in pregnancy or recurrent pregnancy loss, or (Cohort B) following IVF/ART embryo transfer
Study NCT05265299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin 81mg
Description: Aspirin 81mg once daily
Study NCT05432973 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous Electrical Nerve Stimulation
Description: In the PENS treatment, a biphasic continuous waveform current with a frequency of 2 Hz, a pulse width of 50 microseconds and an intensity that produces visible motor responses of the innervated muscles was used, below the patient's pain threshold. The NT6021 Percutaneous Neuromodulation equipment of the Nutek® brand distributed by Fisiolab Ibérica® was used. This equipment has the CE marking, which denotes compliance with the requirements of the legislation of Royal Decree 414/1996 of March 1, which regulates medical devices. B.O.E. of April 24, 1996
Study NCT05432973 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Neurodynamic and manual therapy
Description: The manual therapy consisted of passive-assisted mobilization and massage therapy of the muscular and fascial tissue, beginning with the cervical area, kneading while asking the patient to rotate the neck and then in the same way along the muscles and soft tissues innervated by the target nerve.~Neurodynamic was performed in a passive-assisted manner, combining the patient's cervical mobilizations with the mobility of the upper limbs adapted to each case.
Study NCT05265299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin 162 mg
Description: Aspirin 162 mg once daily
Study NCT05265299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin 325mg
Description: Aspirin 325mg once daily
Study NCT05460806 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: Participants assigned to aerobic exercise training will walk on a treadmill (RodbyTM, RL 1600E, Enhorna, Sweden) for 40 minutes at an intensity of 60-75% of maximum heart rate (220-age formula) three times per week for 8 weeks. The heart rate of the participants will be measured with an electric heart rate monitor throughout the session.
Study NCT04312191 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mantra Meditation
Description: Mantra-based meditation will be taught using a standard one-word mantra (Om). Om is a non-English word that will help with focus as opposed to an English word which may cause distraction based on the word itself.
Study NCT06015113 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disitamab Vedotin plus pyrotinib or naratinib
Description: Trastuzumab Injection: Intravenous infusion, initial loading dose of 2 mg/kg, administered via intravenous infusion over 30-90 minutes (usually recommended around 60 minutes), administered on day 1 of each cycle, with each cycle lasting 14 days.~Pyrotinib Maleate Tablets: 400 mg, taken orally once daily, within 30 minutes after a meal, at the same time every day. Taken continuously, with each cycle lasting 14 days.~Neratinib Maleate Tablets: 240 mg, taken orally once daily with a meal, at the same time every day. The neratinib tablet should be swallowed whole (it should not be chewed, crushed, or split before swallowing). Taken continuously, with each cycle lasting 14 days.
Study NCT04898322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SY-005
Description: 2.5mg of SY-005 for each dose，doses to be given every 12 hours over a period of 5 days
Study NCT04898322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SY-005
Description: 5mg of SY-005 for each dose，doses to be given every 12 hours over a period of 5 days
Study NCT05323903 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telesimulation
Description: Telesimulation is an application that is a teaching process by which telecommunication and healthcare simulation resources are used to provide education, training and assessment to learners at an off-site location. In this study, simulation was recorded and this was shared with the students through means of telecommunication.
Study NCT05323903 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kahoot Game
Description: Kahoot is a game-based learning platform, used as educational technology in schools and other educational institutions.
Study NCT04898322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SY-005
Description: 10mg of SY-005 for each dose，doses to be given every 12 hours over a period of 5 days
Study NCT04898322 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT04859595 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Description: Monthly follow-up by telephone from M1 to M6. The interview will unroll in 2 stages, a first stage of discussion during which the speech therapist will take news of the patient. The second, more formal phase will be the opportunity to collect the data necessary for the validation of the primary and secondary outcomes. To do this, the speech therapist will use the Functional Oral Intake Scale (FOIS) score, the DHI and an interview grid.~The interview will be conducted using an interview sheet previously written by the project team. The following elements will be discussed: the description of oral food intakes (TIMES), the perceived swallowing handicap (DHI), the instructions related to the diet and their daily application, ongoing rehabilitation follow-ups, notable events as well, then his emotional and psychological experience in relation to the disorder.
Study NCT04216823 — intervention group
Intervention type: DEVICE
Intervention: perfusion index
Description: perfusion index in the prediction of peripheral block success was previously reported for infraclavicular brachial plexus block, axillary brachial plexus block, interscalene brachial plexus block, and supraclavicular brachial plexus in adult patients
Study NCT05720546 — intervention group
Intervention type: OTHER
Intervention: Baseline Survey
Description: A survey that measures participant satisfaction will be offered to participants during infusion at baseline.
Study NCT05720546 — intervention group
Intervention type: OTHER
Intervention: Semi-structured interviews
Description: Semi-structured interviews will be conducted in the same infusion spaces.
Study NCT05720546 — intervention group
Intervention type: OTHER
Intervention: Follow-up Survey
Description: A survey that measures participant satisfaction will be offered to participants during following infusion.
Study NCT04806919 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Progesteron TID
Description: increasing the dose
Study NCT04785638 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: INL-001 (bupivacaine hydrochloride) implant
Description: INL-001 (bupivacaine hydrochloride) implant
Study NCT05751304 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: (50 patients) will receive calculated dose of intrathecal hyperbaric bupivacaine 0.5 % according to body weight and 5μg Dexametomidine.
Study NCT05751304 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: (50 patients) will receive calculated dose of intrathecal hyperbaric bupivacaine 0.5 % according to body weight and 0.1 mg/kg ketamine.
Study NCT05611164 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Software assisted selection of individual spermatozoa for intracytoplasmic sperm injection
Description: Half of the oocytes will be injected with a sperm selected with SiD's assistance
Study NCT06254261 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RAY1225
Description: Administered SC